Carboxyl ester lipase (CEL) is involved in the hydrolysis and absorption of dietary lipids, but it is largely unknown to what extent CEL could be involved in determining the serum lipid levels. The C-terminal part of CEL consists of a unique structure with proline-rich O-glycosylated repeats of 11 amino-acid residues each. The common variant of the human CEL gene contains 16 proline-rich repeats, but there is a high degree of polymorphism in the repeated region. While the biological function of the polymorphic repeat region is unknown, it has been suggested that it may be important for protein stability and/or secretion of the enzyme. Given that the polymorphism in the repeated region may affect the functionality of the protein, this study aimed to investigate whether the number of repeated units is correlated to serum lipid phenotype. Comparison of CEL repeat genotype and serum lipid phenotype revealed an association between the number of repeats and serum cholesterol profile. Individuals carrying at least one allele with fewer than the common 16 repeats had significantly lower total and low-density lipoprotein (LDL) cholesterol levels compared to individuals carrying two common alleles. This gives support to the notion that CEL may be involved in determining the plasma lipid composition.
Introduction
Carboxyl ester lipase (CEL), also referred to as bile salt stimulated lipase (BSSL) or bile salt stimulated cholesterol esterase, is a lipolytic enzyme with a wide substrate specificity that can hydrolyse cholesteryl esters, mono-, di-, and triacylglycerol, phospholipids and esters of fatsoluble vitamins. 1 CEL is a secretory enzyme primarily expressed at high levels in the lactating mammary gland and the exocrine pancreas, and it is activated by bile salts in the intestine. CEL constitutes up to 5% of the enzymatic content of the pancreatic juice 2 and has been suggested to be involved in hydrolysis and absorption of dietary lipids. Studies of CEL knockout mice show that lack of CEL appears to have no effect on the intestinal absorption of unesterified fat. 3, 4 However, the cholesteryl ester hydrolytic activity is unique to CEL in the digestive tract, and CEL has been suggested to function as a supplementary enzyme to ensure effective hydrolysis of triglycerides and phospholipids. 5 The C-terminal part of CEL consists of a unique structure with proline-rich O-glycosylated repeats of 11 amino-acid residues each. 6, 7 The repeated units are encoded in exon 11
of the CEL gene. 8 The number of proline-rich repeats varies between species, ranging from three in mouse 9 to 16 in humans 6 and 39 in gorilla, 10 while the salmon CEL gene lacks the repeated region. 11 The mouse CEL is a 74 kDa protein while the human CEL, which is extensively glycosylated across the repeated region, has an apparent molecular mass of 120 -140 kDa. 2, 12 A variation between individuals has been observed in the size of human CEL proteins secreted from the lactating mammary gland into milk, and while the molecular basis for this was initially not clear, indirect evidence suggested that the difference reside in the region of proline-rich repeats located in the C-terminal region of the protein. 13 Recent evidence shows that there is indeed a variation in the number of repeats in the CEL gene and that this variation can account for the observed differences in protein size between individuals.
14 Furthermore, more than 50% of the examined subjects were carriers of alleles that deviate from the common allele containing 16 repeated units, 14 indicating that there is a high degree of polymorphism in the repeated region. This diversity in the number of repeats was later confirmed in another study where alleles containing between 13 and 18 repeats were reported. 15 While the biological function of the polymorphic repeat region is unknown, it has been suggested that it may protect CEL from proteolytic degradation 16 and that Oglycosylation of the repeated sequences is important for the secretion of the enzyme. 17 Although the role of CEL in the intestine is to aid in the absorption of dietary lipids, it is still largely unknown to what extent CEL may be involved in determining the serum lipid levels. Given that the polymorphism in the repeated region may affect the functionality of the protein, we set out to investigate whether the number of repeated units is correlated to serum lipid phenotype. We have genotyped a total number of 263 individuals and correlated their CEL repeat genotype to their plasma lipid profile. We confirm the distribution of CEL repeat genotypes reported previously, 14, 15 and we can here report an association between the number of repeats and serum cholesterol profile. Individuals carrying at least one allele with fewer than the common 16 repeats had lower total cholesterol and low-density lipoprotein (LDL) cholesterol levels compared to individuals carrying two common alleles.
Methods
Subjects DNA extracted from blood samples from individuals participating in the Botnia study 18 There was no significant difference with respect to gender or age between the groups in this subset.
PCR genotyping
The CEL pseudogene, which is present in a tandem arrangement with the CEL gene, 8 contains a corresponding highly variable repeated region. The repeated region in the pseudogene is highly variable with regard to the number of repeats, 19 and it is not unreasonable to assume that it displays the same range of variability as the repeated region in the CEL gene. Although the CEL pseudogene is generally believed to contain fewer repeats than CEL, it could still possibly interfere with the detection of CEL alleles of different length. To resolve this potential problem, we have in this study used a unique set of primers that unequivocally distinguishes between the repeated regions in CEL and the CEL pseudogene. Primers (forward primer: 5 0 -TGGAGATCACCAAGAA-GATGGGCAGCAGC-3 0 , located in exon 11; and reverse primer: 5 0 -CCTGCACCATGATGGTGGCTGCAAGTAAG-3 0 , located downstream of the duplication point in unique sequence, MWG-Biotech AG) were designed on the basis of sequence information from GenBank (Accession number AF072711) to amplify specifically the tandem repeated region of the CEL gene. The reverse primer contained a 5 0 -HEX label to enable detection in the GELSCAN 2000 system (Corbett Research). PCR reactions contained 25 ng genomic DNA and the HotMastertTaq DNA polymerase (Eppendorf) was used with the addition of betaine to a final concentration of 2 M. After an initial denaturation at 961C for 1 min, the following cycle conditions were used: 961C for 1 min, 661C for 1 min, 721C for 1 min for 30 cycles followed by an extended elongation for 7 min at 721C.
The HEX-labelled PCR fragments were analysed in the Gel-Scan 2000 real-time gel electrophoresis system on a denaturing 5% PAGE-Urea gel. GelPro Analyzer (Media Cybernetics) software was used to analyse the results.
Subcloning of PCR fragments and sequencing PCR products selected for sequencing were cloned into a TA vector (Promega) and sequenced in both directions using vector-specific universal primers. The CEQt Dye Terminator Cycle Sequencing kit (Beckman Coulter) was used for the sequencing reactions and the results were analysed using the CEQt 2000XL DNA Analysis System (Beckman Coulter).
Statistical analysis
Group means are expressed as means7SEM and the significance of differences was examined using Student's t-test. Allele and genotype distributions in control vs diabetes groups were assessed using Pearson's w 2 analysis.
Probability values of Po0.05 were considered significant.
Results
Allele and genotype frequencies A total of 263 individuals were genotyped. Of these, 125 were control individuals (67 females and 58 males) and 138 were patients with type II diabetes (77 females and 61 males). The most common allele was the one containing 16 repeats and this allele was designated C (common). Alleles that deviated from the common 16 repeats were designated C þ /À the number of 'extra' or 'missing' repeats. While alleles shorter than the common allele were quite prevalent (B30%), the allele frequency of longer alleles was only approximately 3% (see Table 1 ). There was no significant difference between the distribution of alleles in the control group compared to the patients with type II diabetes (P ¼ 0.1).
The most prevalent genotype (CC, two common alleles) was found in 47% of the individuals. The second most common allele was the CÀ2 allele containing 14 repeats, closely followed by the CÀ1 allele containing 15 repeats. The shortest allele detected in the entire material was CÀ6, corresponding to an allele with only 10 repeats. Carriers of genotypes consisting of one common allele together with any shorter allele accounted for 39% of the total number of individuals. Only 22 individuals (8%) were carriers of two alleles that were shorter than the common allele.
Alleles longer than the common allele were uncommon and were found only in 16 individuals (6%), and the most common genotype including one longer allele was the CC þ 1 genotype. While no genotypes with two longer alleles were found, three individuals were found to have C þ 1 alleles in combination with CÀ2 alleles, and one individual was found to have a combination of C þ 3 and CÀ1 alleles. These four individuals were excluded from further studies, as they would otherwise fall in both categories 'at least one shorter allele' (oC genotype, defined as either one common allele in combination with one shorter allele or two shorter alleles) and 'at least one longer allele' (4C genotype, defined as either one common allele in combination with one longer allele or two longer alleles), and therefore occur twice in the comparisons. There was no significant difference between the distribution of the genotypes CC, oC and 4C in the control group compared to the patients with type II diabetes.
Sequencing of alleles
The classification of genotypes was based on the length of the fragments observed after PCR amplification of the repeated region (a representative section of a gel is shown in Figure 1 ), and was verified by sequencing of a selection of PCR products to confirm that the estimated sizes corresponded to the appointed number of repeats. Totally, 526 alleles with sizes varying from 10 to 19 repeats were detected. The PCR product classified as the CÀ6 allele was shown to contain 10 repeats, a CÀ1 allele 15 repeats, a CÀ2 allele 14 repeats and a C þ 3 allele 19 repeats. The repeats are not entirely identical, and it is therefore possible to a certain extent to distinguish which repeats are missing in the shorter alleles. Hence, sequencing revealed that in the CÀ6 allele the missing repeats were repeat numbers 9, 10, 11, 12, 13 and 14. In the selected CÀ1 allele, repeat number 12 was missing and the CÀ2 sample lacked repeats number 10 and 11. Three extra repeats, corresponding to one additional repeat number 9 and two additional repeats number 10, were inserted between repeats 10 and 11 in the PCR product representing the C þ 3 allele. Figure 1 Representative example of a gel used for genotyping of the alleles. Specific PCR primers, one of which was labelled with the fluorescent label HEX, were used to amplify the region containing the repeats. The resulting PCR products were separated on a PAGE-urea gel and visualised using laser detection.
Comparison of lipid profile between genotypes
The different parameters included in the study of lipid profiles comprised sex, age, body mass index (BMI), waisthip-ratio (WH), plasma cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides (TG) and low-density lipoprotein (LDL) cholesterol. Data were missing or incomplete for 29 of the 263 individuals (eight in the control group and 21 in the diabetes group) and hence they were excluded from further studies. The diabetes group had significantly higher BMI, WH and TG than the control group and also significantly lower HDL, while there were no differences between the groups with respect to total cholesterol or LDL ( Table 2) . Grouping according to genotype such that the first genotype group contained all individuals homozygous for the common allele (CC genotype) and the second group contained all individuals with at least one allele shorter than the common allele (oC genotype) did not reveal any statistically significant differences in either the diabetes or the control group (Table 3) , and power analysis indicated that a larger study group would be required. However, for total cholesterol and for LDL, the same trend, with lower total cholesterol and LDL in the oC group, was observed in both diabetics and controls. Given that total cholesterol and LDL levels did not differ between the diabetes group and the control group (Table 2) and that there is an equal distribution of alleles, as well as CC, oC and 4C genotypes, in the two groups, they were merged for the analysis of genotype influence on total cholesterol and LDL levels. A comparison of the total plasma cholesterol level between the CC (n ¼ 112) and the oC (n ¼ 108) genotypes in the merged group showed that the oC genotype group had significantly lower levels of total plasma cholesterol than the CC genotype group (CC 6.270.1 vs oC 5.870.1 mmol/l, P ¼ 0.044) (Figure 2a) . While no reliable statistical data could be obtained for the group with at least one longer allele due to the low number of subjects in that group (4C, n ¼ 10), the average total plasma cholesterol appeared to be higher than that for the CC group (6.470.5 mmol/l) (Figure 2a) . Analysis of LDL levels showed that the oC genotype carriers had significantly lower LDL plasma level (3.970.1 mmol/l) compared to the CC genotype carriers (4.370.1 mmol/l) (P ¼ 0.045) (Figure 2b ). Similar to the observation for total cholesterol levels, the group with at least one longer allele had higher LDL (4.670.6 mmol/l) than the CC group (Figure 2b) , although this could not be statistically ascertained.
Discussion
The first evidence that the number of repeats in the human CEL gene varies between individuals came from a study by Strömqvist and co-workers on the apparent molecular mass of the CEL protein secreted into milk. 13 They found a variation in the size of CEL proteins that could not be explained by differences in carbohydrate content, and indirect evidence suggested that the difference resides in a region of repeats located in the C-terminal region of the protein. 13 Following up on this, Lindquist et al 14 recently
reported that there is indeed a variation in the number of repeats between individuals. Their study of a restriction polymorphism within exon 11 of the CEL gene showed that as many as 56% of the study subjects were carriers of alleles with a number of repetitions that varied from the common 16 repeat allele. Direct sequencing of two of the P-values are indicated where statistically significant differences were found. shorter alleles confirmed that the deletions were within the region of the repeats. 14 Another study later confirmed this diversity in the number of repeats and proceeded to compare the allele frequencies in a Caucasian and a Japanese population. 15 This latter study reported that 65% of the Caucasian subjects are heterozygous for alleles with 14 to 18 repeats in exon 11 of the CEL gene, while 44% of the Japanese subjects are heterozygous for alleles with 13 to 18 repeats. Although there was a tendency towards a difference in allele distribution between the populations, it did not reach statistical significance. 15 The role of the repeats in CEL exon 11 is not clear, although there are indications to suggest that they may protect CEL from proteolytic degradation 16 and that Oglycosylation of the repeated sequences could be important for the secretion of the enzyme. 17 27 close to the ABO blood group antigen locus, which has been associated with lipid phenotype and cardiovascular disease. 28 It is possible that the association between lipid profile and the ABO locus is due to a polymorphism in the CEL gene. 27 The present study is the first to investigate association between a putatively functional variation in the CEL gene and lipid profile, and we found an association between shorter CEL alleles (ie fewer repeats than the common 16) and lower total cholesterol as well as lower LDL. A possible explanation for this observation could be that CEL proteins with fewer proline-rich repeats are secreted at a lower rate and/or are less well protected from degradation in the intestinal tract, and therefore less Figure 2 Differences in total cholesterol and LDL between genotype groups. Graphic illustration of the differences between the CC, oC and 4C genotypes in the merged group (diabetes and control) with respect to total cholesterol (a) and LDL (b). Bars represent mean values7SE and *Po0.05.
efficiently aid the hydrolysis and uptake of cholesterol dietary lipids. It is also possible that circulating CEL modulates serum lipid profile outside the intestinal tract. A study by Brodt-Eppley et al 29 showed a positive correlation between levels of CEL and LDL in the plasma, while there appeared to be no correlation between CEL and HDL. Future studies are warranted to investigate whether the polymorphism in the repeated region of the CEL gene affects serum levels of circulating CEL. The result of the current study gives further support to the notion that CEL may be involved in determining the plasma lipid composition. Future experiments aimed at determining the functional effect of variable number of repeats, such as measuring the rate of CEL secretion or enzyme activity in individuals with different repeat number genotypes will help elucidate whether the repeats play a role in regulating CEL secretion and activity.
